Cargando…

Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day

Background: In advanced bladder cancer (BCa), platinum-based chemotherapy represents the first-choice treatment. In the last ten years, immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape of many solid tumors. Our review aims to summarize the main findings regarding the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiorano, Brigida Anna, De Giorgi, Ugo, Ciardiello, Davide, Schinzari, Giovanni, Cisternino, Antonio, Tortora, Giampaolo, Maiello, Evaristo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962271/ https://www.ncbi.nlm.nih.gov/pubmed/35203620 http://dx.doi.org/10.3390/biomedicines10020411

Ejemplares similares

Cancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
por: Maiorano, Brigida Anna, et al.
Publicado: (2021)

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
por: Maiorano, Brigida Anna, et al.
Publicado: (2021)

The Interplay between Anti-Angiogenics and Immunotherapy in Colorectal Cancer
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Comparison of Anti–Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma: A Meta-analysis
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
por: Rossi, Ernesto, et al.
Publicado: (2020)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Seize the day
por: McCutcheon, Sharon
Publicado: (2022)

Efficacy of immune checkpoint inhibitors in different types of melanoma
por: Rossi, Ernesto, et al.
Publicado: (2020)

Niraparib and Advanced Ovarian Cancer: A Beacon in the Non-BRCA Mutated Setting
por: Maiorano, Mauro Francesco Pio, et al.
Publicado: (2023)

Seize the day : Lester B. Pearson and crisis diplomacy /
por: Pearson, Geoffrey A. H.
Publicado: (1993)

Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Clinic, Endoscopic and Histological Features in Patients Treated with ICI Developing GI Toxicity: Some News and Reappraisal from a Mono-Institutional Experience
por: Parente, Paola, et al.
Publicado: (2022)

Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
por: Maiorano, Brigida Anna, et al.
Publicado: (2022)

Pregnancy Effects on Seizure Frequency: To Seize or Not to Seize
por: Becker, Danielle A.
Publicado: (2021)

Immunotherapy for Biliary Tract Cancer in the Era of Precision Medicine: Current Knowledge and Future Perspectives
por: Ciardiello, Davide, et al.
Publicado: (2022)

Seize the Day for a Day With No Seizures: Modifiable Midlife Risk Factors Identified
por: Koubeissi, Mohamad
Publicado: (2019)

Seizing an opportunity
por: Zurn, Perry, et al.
Publicado: (2019)

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Checkpoint Inhibitors for Advanced Bladder Cancer
por: Messing, Edward M.
Publicado: (2016)

To Not Sleep, Perchance to Seize
por: Stafstrom, Carl E.
Publicado: (2022)

Advances and Controversies With Checkpoint Inhibitors in Bladder Cancer
por: Rhea, Logan P, et al.
Publicado: (2021)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study
por: Rossi, Ernesto, et al.
Publicado: (2023)

Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019)

Seize opportunities and jointly advance China-EU economic and trade relations
por: Xia, Xiang
Publicado: (2021)

Seizing the Light, 3rd ed.
por: Hirsch, Robert
Publicado: (2017)

Profiling of Ecstasy Tablets Seized in Iran
por: Khajeamiri, Ali Reza, et al.
Publicado: (2011)

Human Microglia Seize the Chance to be Different
por: Brewster, Amy L.
Publicado: (2019)

Seizing the Neuroinflammatory Target: The Quest Continues
por: Sharma, Ayushe A., et al.
Publicado: (2019)

Family medicine in Tanzania: Seize the moment
por: Ratanzi, Riaz, et al.
Publicado: (2020)

Dataset of seized wildlife and their intended uses
por: Stringham, Oliver C., et al.
Publicado: (2021)

Seizing the moment to rethink health systems
por: Nimako, Kojo, et al.
Publicado: (2021)

“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
por: Sollena, Pietro, et al.
Publicado: (2021)

CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as a Rechallenge Strategy in Pre-Treated RAS/BRAF Wild-Type mCRC Patients
por: Napolitano, Stefania, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?
por: Modena, Alessandra, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ram42tsd9p3m6s6jf5v01eo4ib